RSS Feed - 商业诉讼 - Kaye Scholer LLP
Current Feed: http://www.kayescholer.com/practice/rss.xml?p=commercial_litigation
Randall L. Speck (06/19/13)
Randall Speck is responsible for major administrative, litigation, and arbitration matters in the firm’s Washington, DC office. For more than 30 years, Mr. Speck has handled a variety of complex proceedings involving electric industry restructuring, development and implementation of organized electric markets, multibillion-dollar contract disputes, design and construction projects, antitrust claims, alleged fraud, and negligence suits. He has represented state public utility commissions in major proceedings at the Federal Energy Regulatory Commission (“FERC”) and before the U.S. Courts of Appeals relating to electric resource adequacy, the exercise of market power in wholesale electricity markets, and incentive rates of return. Recently, he has represented a major electric utility in a state regulatory proceeding involving the prudence of costs incurred in building a first-of-a-kind-at-its-size baseload power plant and has represented a major U.S. electrical equipment manufacturer in a simultaneous lawsuit and international arbitration over the award and performance of a contract to build a nuclear power plant in the Philippines, including a $2 billion arbitration proceeding. He has represented a number of major U.S. and international manufacturers in multimillion-dollar contract disputes and arbitration matters involving such issues as the international rights to sell patented HIV tests, the development and marketing of generic drugs in the United States, contracts to supply radar equipment to a country in the Middle East in the 1970s, and alleged fraud in the manufacture of communications satellite components. He successfully represented a class of former shareholders in a suit to enforce a letter agreement to pay them a percentage of the gain realized on any resale of cellular telephone assets.
Amanda Lanham (06/19/13)
Amanda Lanham is an Associate in the Litigation Department of Kaye Scholer.
Susanna Chu (06/19/13)
Susanna Chu focuses her practice on complex litigation at the trial and appellate levels. Her work spans a variety of subject areas, including banking and finance matters, energy litigation, and statutory interpretation and constitutional issues.
Phillip A. Geraci (06/19/13)
Phillip A. Geraci practices in Kaye Scholer’s Complex Commercial Litigation Department with an emphasis on securities, derivatives, and commodities litigation, including defense of securities fraud class actions and shareholder derivative actions, representation of corporate clients in SEC investigations, takeover and proxy contest litigation, defense of commodities manipulation and fraud actions, and litigations involving limited partnerships and their sponsors. He has tried cases involving securities, commodities, foreign exchange futures and options, derivatives, contracts, and trademarks.
Aaron Rubinstein (06/19/13)
Aaron Rubinstein is a Partner in the Litigation Department and Chair of the Financial Services Litigation Practice Group. Aaron recently completed a twelve-year term as Chair of the Litigation Department. He has 35 years of experience representing defendants and plaintiffs in complex commercial litigations, including securities, commodities, derivatives and contract claims. He handles both private suits, including class actions and shareholder derivative actions, and proceedings before government enforcement agencies. His representations have been of a wide variety of clients, including public and privately held corporations, directors of such companies, individuals, and some of the largest financial institutions, both domestic and international.
Dr. Annette Bödeker, LL.M. (06/13/13)
Dr. Annette Bödeker is a member of the Corporate Group and serves as Head of the Corporate Department in Frankfurt. Dr. Bödeker is an accomplished corporate lawyer with a broad client base including German and international corporations as well as financial institutions.
Lori B. Leskin (06/10/13)
Lori B. Leskin, Partner and Co-Chair of the Product Liability group, is valued by her clients for her ability to successfully assess, strategize and implement unique solutions to their unique problems. Lori’s leadership is evidenced by her appointment as Co-Chair of the Products Liability Committee of the American Bar Association’s Section of Litigation and her inclusion in The Legal 500 US 2013 for Litigation - Product liability and mass tort defense: pharmaceuticals and medical devices. Lori is also recognized by US News & World Report Best Lawyers 2013, which ranks Kaye Scholer as a National Tier 1 firm for Mass Tort Litigation/Class Actions – Defendants. Additionally, she was shortlisted for the 2013 Euromoney LMG Americas Women in Business Law Awards for the “Best in Litigation” category. She was also recognized as a leader in New York Mass Tort Litigation/Class Actions by The Best Lawyers in America 2013. In 2012 she was named “Life Science Star” in the inaugural issue of Euromoney’s LMG Life Sciences Guide and placed among the The International Who’s Who of Life Sciences Lawyers 2010-2012, which recognized Kaye Scholer as “one of the most well regarded firms” for Life Sciences. Her Products Liability practice group was named Product Liability Firm of the Year at the 2008 Chambers and Partners “USA Awards for Excellence” ceremony and “Best Product Liability Practice” in January 2006 by The American Lawyer. In 2012 her group was also ranked as a top tier practice by Chambers USA, and was referenced as “[A]bsolute experts and incredible strategic thinkers. They have the ability to understand their client and what we are most concerned about, and getting to the objective in the most cost-effective and efficient manner while ensuring you get the results you want.”
Arthur E. Brown (06/06/13)
Arthur E. Brown is Co-Chair of Kaye Scholer’s Product Liability Group, and a member of the firm’s Complex Commercial Litigation Group. His practice focuses on representing and advising clients on mass tort and product liability issues, investigations by federal and state authorities, inquiries from Congress, and commercial litigation disputes. As part of his practice, Arthur frequently serves as national counsel representing pharmaceutical companies in mass tort product liability actions, advises clients on strategic litigation and settlement decisions in the areas of commercial litigation and white collar investigations, and counsels clients on litigation avoidance.